RPRX filings
Corporate insider profile
Terrance P. Coyne Filing Activity
Latest reported as EVP & CFO of Royalty Pharma plc (RPRX).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$5,207,956.66
- Latest transaction
- May 26, 2026
Transaction history
